NEPHROS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
NEPHROS, INC. (NEPH) reported Cash and Cash Equivalents, Period Increase (Decrease) of $468.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2014-11-13
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2014-09-30 was $822.00K.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2014-06-30 was -$248.00K, a 550.91% decline year-over-year.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2014-03-31 was -$106.00K, a 154.08% decline year-over-year.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-12-31 was $411.00K.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $532.00K.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2012 was -$1.62M, a 213.51% decline from fiscal 2011.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2011 was $1.43M.
- NEPHROS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2010 was -$764.00K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $822.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $574.00K derived: sum of 2 quarters · filed 2014-11-13 | $468.00K 10-Q · filed 2014-11-13 | $879.00K derived: sum of 4 quarters · filed 2014-11-13 |
| 2014-06-30 | -$248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$354.00K 10-Q · filed 2014-08-14 | $57.00K derived: sum of 3 quarters · filed 2014-08-14 | -$73.00K derived: sum of 4 quarters · filed 2014-11-13 |
| 2014-03-31 | -$106.00K 10-Q · filed 2014-05-14 | $305.00K derived: sum of 2 quarters · filed 2014-05-14 | $175.00K derived: sum of 3 quarters · filed 2014-11-13 | $230.00K derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $281.00K derived: sum of 2 quarters · filed 2014-11-13 | $336.00K derived: sum of 3 quarters · filed 2014-11-13 | $532.00K 10-K · filed 2014-03-28 |
| 2013-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$75.00K derived: sum of 2 quarters · filed 2014-11-13 | $121.00K 10-Q · filed 2014-11-13 | -$198.00K derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $251.00K 10-Q · filed 2014-08-14 | -$68.00K derived: sum of 3 quarters · filed 2014-08-14 | -$689.00K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $196.00K 10-Q · filed 2014-05-14 | -$123.00K derived: sum of 2 quarters · filed 2014-05-14 | -$744.00K derived: sum of 3 quarters · filed 2014-05-14 | -$1.93M derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | -$319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$940.00K derived: sum of 2 quarters · filed 2014-03-28 | -$2.13M derived: sum of 3 quarters · filed 2014-03-28 | -$1.62M 10-K · filed 2014-03-28 |
| 2012-09-30 | -$621.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.81M derived: sum of 2 quarters · filed 2013-11-14 | -$1.30M 10-Q · filed 2013-11-14 | -$1.75M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$682.00K 10-Q · filed 2013-08-13 | -$1.13M derived: sum of 3 quarters · filed 2013-08-13 | -$726.00K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $505.00K 10-Q · filed 2013-05-08 | $57.00K derived: sum of 2 quarters · filed 2013-05-08 | $461.00K derived: sum of 3 quarters · filed 2013-05-08 | -$73.00K derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | -$448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-04 | -$44.00K derived: sum of 2 quarters · filed 2013-03-04 | -$578.00K derived: sum of 3 quarters · filed 2013-03-04 | $1.43M 10-K · filed 2013-03-04 |
| 2011-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$130.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.88M 10-Q · filed 2012-11-09 | $1.70M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | -$534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.47M 10-Q · filed 2012-08-14 | $1.29M derived: sum of 3 quarters · filed 2012-08-14 | $1.37M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $2.01M 10-Q · filed 2012-05-15 | $1.83M derived: sum of 2 quarters · filed 2012-05-15 | $1.90M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | -$104.00K derived: sum of 2 quarters · filed 2012-03-22 | -$764.00K 10-K · filed 2012-03-22 | |
| 2010-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$583.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$660.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |